Immunogenicity 15324
Sample ID
patient3
Response
Negative
Tumor Type
Melanoma
Gene Symbol
TMEM237
Transcript ID
None
HLA INFO
A*02:01
TCR INFO
No TCR info found!
Full length protein sequence (408 aa)
MRTDS
1
GARLE
6
EGHLR
11
PPRAL
16
PPVPS
21
QDDIP
26
LSRPK
31
KKKPR
36
TKNTP
41
ASASL
46
EGLAQ
51
TAGRR
56
PSEGN
61
EPSTK
66
ELKEH
71
PEAPV
76
QRRQK
81
KTRLP
86
LELET
91
SSTQK
96
KSSSS
101
SLLRN
106
ENGID
111
AEPAE
116
EAVIQ
121
KPRRK
126
TKKTQ
131
PAELQ
136
YANEL
141
GVEDE
146
DIITD
151
EQTTV
156
EQQSV
161
FTAPT
166
GISQP
171
VGKVF
176
VEKSR
181
RFQAA
186
DRSEL
191
IKTTE
196
NIDVS
201
MDVKP
206
SWTTR
211
DVALT
216
VHRAF
221
RMIGL
226
FSHGF
231
LAGCA
236
VWNIV
241
VIYVL
246
AGDQL
251
SNLSN
256
LLQQY
261
KTLAY
266
PFQSL
271
LYLLL
276
ALSTI
281
SAFDR
286
IDFAK
291
ISVAI
296
RNFLA
301
LDPTA
306
LASFL
311
YFTAL
316
ILSLS
321
QQMTS
326
DRIHL
331
YTPSS
336
VNGSL
341
WEAGI
346
EEQIL
351
QPWIV
356
VNLVV
361
ALLVG
366
LSWLF
371
LSYRP
376
GMDLS
381
EELMF
386
SSEVE
391
EYPDK
396
EKEIK
401
ASS
406
Mutation Information
DNA mutation:
None
Peptide Range:
267 ~ 275
Mut AA position:
271 (5 in Wild Type peptide)
Alignment
Wild Type:
"TLAYPFQSL
||||.||||
Mutant:
TLAYSFQSL"
Science, 2016
Targeting of cancer neoantigens with donor-derived T cell receptor repertoiresGene Name (from Reference) ALS2CR4
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
MoDCs
Assay
IFNg ELISPOT assay